Insulin and its role in chronic kidney disease

Pediatric Nephrology

Volumn 23, Issue 3, 2008, Pages 355-362

  Mak, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anemia; Chronic kidney disease; End stage renal disease; Insulin resistance; Insulin secretion; Uremia; Vitamin D

Indexed keywords

CALCITRIOL; ERYTHROPOIETIN; GLUCOSE; INSULIN; UREMIC TOXIN;

ANEMIA; ATHEROSCLEROSIS; CACHEXIA; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; FITNESS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GROWTH RETARDATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INFLAMMATION; INSULIN CLEARANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY FAILURE; METABOLIC ACIDOSIS; METABOLIC SYNDROME X; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN RESTRICTION; PUBERTY; REVIEW; RISK FACTOR; VITAMIN D DEFICIENCY;

CARDIOVASCULAR DISEASES; CHILD; CHRONIC DISEASE; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY DISEASES; PREVALENCE;

EID: 38649105179     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0611-2     Document Type: Review

References (74)

1. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Wahren J (1981) Insulin resistance in uremia. J Clin Invest 67:563-568
2. Mak RH, Haycock GB, Chantler C (1983) Glucose intolerance in children with chronic renal failure. Kidney Int 24(Suppl 15):S22-S26
3. Mak RH, DeFronzo RA (1992) Glucose and insulin metabolism in uremia. Nephron 61:377-382
4. Wahba I, Mak RH (2007) Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2:550-562
5. Rabkin R, Simon NM, Steiner S, Colwell JA (1970) Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 282:182-187
6. Mondon CE, Dolkas CB, Reaven GM (1978) Effect of acute uremia on insulin removal by the isolated perfused rat liver and muscle. Metabolism 27:133-142
7. Friedman JE, Dohm GL, Elton CW, Rovira A, Chen JJ, Leggett-Frazier N, Atkinson SM, Thomas FT, Long SD, Caro JF (1991) Muscle insulin resistance in uremic humans: Glucose transport, glucose transporters and insulin receptors. Am J Physiol 261:E87-E94
8. Alvestrand A (1997) Carbohydrate and insulin metabolism in renal failure. Kidney Int 52(Suppl 62):S48-S52
9. Contreras I, Caro JF, Aveledo L, Diaz K, Durrego P, Weisinger JR (1992) In chronic uremia, insulin activates receptor kinase but not pyruvate dehydrogenase. Nephron 61:77-81
10. Bailey JL, Zheng B, Hu Z, Prive SR, Mitch WE (2006) Chronic kidney disease causes defects in signaling through insulin receptor substrate/ phosphoinositol 3-kinase/Akt pathway: Implications for muscle wasting. J Am Soc Nephrol 17:1388-1394
11. McCaleb ML, Izzo MS, Lockwood DH (1985) Characterization and partial purification of a factor from uremic serum that induces insulin resistance. J Clin Invest 75:391-396
12. Dzuric R, Spustova V, Lajdova I (1993) Inhibition of glucose utilization in isolated rat soleus muscle by pseudouridine: Implications for renal failure. Nephron 65:108-110
13. Mak RH (1996) Insulin resistance in uremia: Effect of dialysis modality. Pediatr Res 40:304-308
14. Mak RH, Turner C, Thompson T, Haycock GB, Chantler C (1986) The effect of dietary protein restriction and amino acid/keto acid supplements on glucose metabolism in uremic children. J Clin Endocrinol Metabol 63:985-989
15. Rigalleau V, Combe C, Blanche V, Aubertin J, Apacicio M, Gin H (1997) Low protein diet in uremia. Effect of glucose metabolism and energy production rate. Kidney Int 51:1222-1227
16. Mak RH (1998) 1,25 vitamin D3 corrects insulin and lipid abnormalities in uremia. Kidney Int 53:1353-1357
17. Mak RH (1998) Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int 54:603-607
18. Ford ES, Ajani UA, McGuire LC, Liu S (2005) Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28:1228-1230
19. Chonchol M, Scragg R (2007) 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71:134-139
20. Eidmak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strangaard S (1995) Insulin resistance and hyperinsulinemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 38:565-572
21. Goldberg A, Hagberg J, Delmez J, Haynes ME, Harter HR (1989) The metabolic effects of exercise training in hemodialysis patients. Kidney Int 18:754-761
22. Mak RH (1996) Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol 270:F839-F894
23. Mak RH (1996) The effect of erythropoietin on insulin, amino acid and lipid metabolism in uremia. J Pediatr 129:97-104
24. Mak RH (1998) Metabolic effects of erythropoietin in uremic patients on peritoneal dialysis. Pediatr Nephrol 12:660-665
25. Siew ED, Pupim LB, Majchrzak KM, Shintani A, Flakoll PJ, Ikizler TA (2007) Insulin resistance is associated with skeletal muscle breakdown in non-diabetic chronic hemodialysis patients. Kidney Int 71:146-152
26. Church JM, Hill GL (1988) Impaired glucose metabolism in surgical patients improved by intravenous nutrition: Assessment by euglycemic-hyperinsulinemic clamp. Metabolism 37:505-509
27. Mak RH Cheung W, Cone R, Marks DL (2005) Orexigenic and anorexigenic mechanisms in the control of nutrition in chronic kidney disease. Pediatr Nephrol 20:427-431
28. Mak RH, Cheung W, Cone R, Marks DL (2006) Energy homeostasis and cachexia in chronic kidney disease. Pediatr Nephrol 21:1807-1814
29. Lai HL, Kartal J, Mitsnefes M (2007) Hyperinsulinemia in pediatric patients with chronic kidney disease: The role of tumor necrosis factor-alpha. Pediatr Nephrol DOI 10.1007/s00467-007-0533-z
30. Mak RH, Bettinelli A, Turner C, Haycock GB, Chantler C (1985) The influence of hyperparathyroidism on glucose metabolism in uremia. J Clin Endocrinol Metab 60:229-233
31. Mak RH, Turner C, Haycock GB, Chantler C (1983) Secondary hyperparathyroidism and glucose intolerance in children with uremia. Kidney Int 24(Suppl 16):S128-S133
32. Akmal M, Massry SG, Goldstein D, DeFronzo RA (1985) The role of parathyroid hormone in the glucose intolerance in uremia. J Clin Invest 75:1037-1044
33. Mak RH (1992) 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 41:1049-1054
34. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
35. Horgaard A, Thayssen TH (1929) Clinical investigation into the effect of the intravenous injection of insulin. Acta Med Scand 72:92-95
36. Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-48
37. Bergman RN, Prager R, Volund A, Olefsky JM (1987) Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 79:790-800
38. Hosker JP, Matthews DR, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:401-411
39. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ (2000) Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
40. Maddux BA, Chan A, Mandarino LJ, Goldfine ID (2006) IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 29:1535-1537
41. Reaven G (1997) The kidney: An unwilling accomplice in syndrome X. Am J Kidney Dis 30:928-931
42. Liu Z (2007) The renin-angiotensin system and insulin resistance. Curr Diab Rep 7:34-42
43. Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME (2005) Why blockade of the rennin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 23:463-473
44. Klahr S, Morrissey JJ (2000) The role of vasoactive compounds, growth factor and cytokines in the progression of renal disease. Kidney Int 75(Suppl):S7-S14
45. Chan MK, Varghese Z, Moorhead JF (1981) Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int 19:625-637
46. Saland JM, Ginsberg HN (2007) Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 22:1095-1112
47. Kaysen GA (2006) Metabolic syndrome and renal failure. Panminerva Med 48:151-164
48. Fadini GP, Pauletto P, Avogaro A, Rattazzi M (2007) The good and the bad in the link between insulin resistance and vascular calcification. Atherosclerosis 193:241-244
49. Chen NX, Duan D, O'Neill KD, Moe SM (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21:3435-3442.
50. Olesen P, Nguyen K, Wogensen L, Ledet T, Rasmussen LM (2007) Calcification of human vascular smooth muscle cells: Associations with osteoprotegerin expression and acceleration by high-dose insulin. Am J Physiol Heart Circ Physiol 292:H1058-H1064
51. Baxter RC, Turtle JR (1978) Regulation of growth hormone receptors by insulin. Biochem Biophy Res Com 84:350-357
52. Daughaday WH, Philips LS, Mueller MC (1976) The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinol 98:1214-1219
53. Maes M, Underwood LE, Ketelslegers JM (1986) Low serum somatomedin-C in insulin-dependent diabetes: Evidence for a postreceptor mechanism. Endocrinol 118:377-382
54. Cotterill AM, Cowell CT, Silink M (1989) Insulin and variation in glucose levels modify the secretion rates of the growth hormone-dependent insulin-like growth factor binding protein-1 in the human hepatoblastoma cell-line Hep G2. J Endocrinol 12:R17-R20
55. Dunger DB, Cheetham TD (1996) Growth hormone-insulin-like growth factor-I axis in insulin-dependent diabetes mellitus. Horm Res 46:2-6
56. Mak RH (1995) Insulin secretion and growth in uremia. Pediatr Res 38:379-383
57. Mak RH (1998) Insulin, branched-chain amino acids and growth failure in uremia. Pediatr Nephrol 12:637-642
58. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J (2004) The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 140:167-174
59. Peralta CA, Kurella M, Lo JC, Chertow GM (2006) The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 15:361-365
60. Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Am Soc Nephrol 16:2134-2140
61. Palaniappan L, Carnethon M, Fortmann SP (2003) Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 16:952-958
62. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A (2004) Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 22:1991-1998
63. Mule G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, Mongiovì R, Mezzatesta G, Andronico G, Cerasola G (2005) Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 257:503-513
64. Godfrey KM, Barker DJ (2000) Fetal nutrition and adult disease. Am J Clin Nutr 71:1344S-1352S
65. Hinchliffe SA, Lynch MR, Sergent PH, Howard CV, Van Velzen D (1992) The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 99:296-301
66. MacDonald MD, Emery JL (1959) The late intrauterine and postnatal development of human renal glomeruli. J Anat 93:331-340
67. Manalich R, Reyes L, Herrera M, Melendi C, Fundora I (2000) Relationship between weight at birth and the number and size of glomeruli in humans: A histomorphometric study. Kidney Int 58:770-773
68. Brenner BM, Lawler EV, Mackenzie HS (1996) The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49:1774-1777
69. Brenner BM, Chertow GM (1993) Congenital oligonephropathy: An inborn cause of adult hypertension and progressive renal injury? Curr Opin Nephrol Hypertens 2:691-895
70. Keller G, Zimmer G, Mall, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101-108
71. Wellen KE, Hotamisligil GS (2003) Obesity-induced inflammatory changes in adipose tisuue. J Clin Invest 112:1785-1788
72. Engeli S, Sharma AM (2000) Role of adipose tissue for cardiovascular-renal regulation in health and disease. Horm Metab Res 32:485-499
73. Knight SF, Imig JD (2007) Obesity, insulin resistance and renal function. Microcirculation 14:349-362
74. Sarafidis PA, Ruilope LM (2006) Insulin resistance, hyperinsulinemia and renal injury: Mechanism and implications. Am J Nephrol 26:232-244